Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Paratek Pharmaceuticals Inc

+ Add to Watchlist

PRTK:US

25.5100 USD 1.1800 4.85%

As of 20:10:00 ET on 05/01/2015.

Snapshot for Paratek Pharmaceuticals Inc (PRTK)

Open: 24.5000 Day's Range: 23.4100 - 25.9500 Volume: 73,871
Previous Close: 24.3300 52wk Range: 11.2979 - 39.7956 1-Yr Rtn: +77.95%

Stock Chart for PRTK

No chart data available.
  • PRTK:US 25.5100
  • 1D
  • 1M
  • 1Y
24.3300
Interactive PRTK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PRTK

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -9.5448
Est. EPS (USD) (12/2015) -
Est. PEG Ratio -
Market Cap (M USD) 440.76
Shares Outstanding (M) 17.28
30 Day Average Volume 79,072
Price/Book (mrq) 0.3219
Price/Sale (ttm) 11.3485
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 8.0088
Dividend Ex-Date 10/31/2014
5 Year Dividend Growth -
Next Earnings Announcement 05/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PRTK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PRTK

Paratek Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the development and commercialization of antibiotics. The Company develops medicine for serious community-acquired bacterial infections. Paratek Pharmaceuticals' products treat patients in both the community and hospital setting.

Michael F BighamChairman/CEOEvan LohPresident/Chief Medical Ofcr
Douglas W PaganChief Financial OfficerAlan MendelsonSecretary
More Company Profile & Key Executives for PRTK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil